Our Cardiovascular Disease Experience by the Numbers
- >200 Cardiovascular Trials for drugs, biologics, devices, and diagnostics
- 5 Approved Marketing Applications to date
- 42% of the Cardiovascular Trials for rare diseases
A mid-size pharmaceutical company and its development partner, a small biotechnology company engaged Veristat to complete the medical writing for their product’s ...
With Cardiovascular Diseases being the leading cause of death worldwide, Veristat is committed to supporting cardiovascular clinical trials to make a difference in ...
When Veristat partnered with a US based biotechnology company on a Phase II study for a topical spray to treat hypertension, our emphasis on effective planning and ...
